[Chemotherapeutic effectiveness of antibiotics in combination with papain in experimental septicemia]. 1984

G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii

The efficacy of papain, a proteolytic enzyme made in the USSR, was studied alone and in combination with antibiotics, such as benzylpenicillin, streptomycin, chloramphenicol, tetracycline, erythromycin and novobiocin in treatment of mice with septicemia caused by antibiotic-resistant staphylococci. It was shown that the enzyme increased the chemotherapeutic efficacy of the antibiotics on the average by 50 per cent. When used alone in a dose of 0.1 mg per mouse papain prevented death in 20 per cent of animals. The high chemotherapeutic efficacy of the antibiotic combinations with papain allowed recommending it for use in clinical practice for the treatment of infections caused by antibiotic-resistant staphylococci.

UI MeSH Term Description Entries
D010206 Papain A proteolytic enzyme obtained from Carica papaya. It is also the name used for a purified mixture of papain and CHYMOPAPAIN that is used as a topical enzymatic debriding agent. EC 3.4.22.2. Tromasin
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
April 1956, La Revue du praticien,
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
April 1961, Antibiotics & chemotherapy (Northfield, Ill.),
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
September 1976, Antibiotiki,
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
December 1994, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
January 1991, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
January 1980, Infection,
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
August 1972, Casopis lekaru ceskych,
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
January 1967, Meditsinskaia parazitologiia i parazitarnye bolezni,
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
January 1977, Annali Sclavo; rivista di microbiologia e di immunologia,
G Sh Baskanchiladze, and L A Khurtsilava, and I A Gelovani, and M V Asatiani, and V I Rossinskii
April 1979, Antibiotiki,
Copied contents to your clipboard!